365 related articles for article (PubMed ID: 28139023)
1. Investigation of the predictive validity of laser-EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers.
Schaffler K; Nicolas LB; Borta A; Brand T; Reitmeir P; Roebling R; Scholpp J
Br J Clin Pharmacol; 2017 Jul; 83(7):1424-1435. PubMed ID: 28139023
[TBL] [Abstract][Full Text] [Related]
2. Dose-response relationship after single oral dose administrations of morphine and oxycodone using laser-evoked potentials on UVB- and capsaicin-irritated skin in healthy male subjects.
Hoeben E; Smit JW; Upmalis D; Rusch S; Schaffler K; Reitmeir P; Mangold B
Pain; 2012 Aug; 153(8):1648-1656. PubMed ID: 22703892
[TBL] [Abstract][Full Text] [Related]
3. An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin.
Schaffler K; Reeh P; Duan WR; Best AE; Othman AA; Faltynek CR; Locke C; Nothaft W
Br J Clin Pharmacol; 2013 Feb; 75(2):404-14. PubMed ID: 22775239
[TBL] [Abstract][Full Text] [Related]
4. Analgesic effects of low-dose intravenous orphenadrine in the state of capsaicin hyperalgesia. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from capsaicin-irritated skin in healthy volunteers.
Schaffler K; Reitmeir P
Arzneimittelforschung; 2004; 54(10):673-9. PubMed ID: 15553107
[TBL] [Abstract][Full Text] [Related]
5. IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG).
Mouraux A; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Di Stefano G; Finnerup NB; Garcia-Larrea L; Goetz M; Kostenko A; Pelz B; Pogatzki-Zahn E; Schubart K; Stouffs A; Truini A; Tracey I; Troconiz IF; Van Niel J; Vela JM; Vincent K; Vollert J; Wanigasekera V; Wittayer M; Phillips KG; Treede RD
Trials; 2021 Jun; 22(1):404. PubMed ID: 34140041
[TBL] [Abstract][Full Text] [Related]
6. A Phase I, Randomized, Double-Blind, Laser-Evoked Potential Study to Evaluate the Analgesic/Antihyperalgesic Effect of ASP9226, a State-Dependent N-Type Voltage-Gated Calcium Channel Inhibitor, in Healthy Male Subjects.
Schaffler K; He W; Passier P; Tracy K; Fakhoury A; Paul J
Pain Med; 2018 Nov; 19(11):2246-2255. PubMed ID: 29378016
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two different preparations of ibuprofen with regard to the time course of their analgesic effect. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from UW-irritated skin in healthy volunteers.
Seibel K; Schaffler K; Reeh P; Reitmeir P
Arzneimittelforschung; 2004; 54(8):444-51. PubMed ID: 15460211
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentials from capsaicin-induced hyperalgesic human skin.
Schaffler K; Reitmeir P; Gschanes A; Eggenreich U
Drugs R D; 2005; 6(4):189-99. PubMed ID: 15991879
[TBL] [Abstract][Full Text] [Related]
9. A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects.
Schaffler K; Yassen A; Reeh P; Passier P
Pain Med; 2018 Jun; 19(6):1206-1218. PubMed ID: 29228247
[TBL] [Abstract][Full Text] [Related]
10. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity.
Leone C; Di Stefano G; Di Pietro G; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Finnerup NB; Garcia-Larrea L; Li T; Goetz M; Mouraux A; Pelz B; Pogatzki-Zahn E; Schilder A; Schnetter E; Schubart K; Tracey I; Troconiz IF; Van Niel H; Hernandez JMV; Vincent K; Vollert J; Wanigasekera V; Wittayer M; Phillips KG; Truini A; Treede RD
Trials; 2022 Sep; 23(1):739. PubMed ID: 36064434
[TBL] [Abstract][Full Text] [Related]
11. Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects.
Wang H; Bolognese J; Calder N; Baxendale J; Kehler A; Cummings C; Connell J; Herman G
J Pain; 2008 Dec; 9(12):1088-95. PubMed ID: 19038771
[TBL] [Abstract][Full Text] [Related]
12. Effect of the new H1-antagonist ReN1869 on capsaicin-induced hyperalgesia in human skin/Human phase-I trial using somatosensory evoked potentials induced by a CO2 laser.
Schaffler K; Seibel K; Thomsen M; Edwards M
Arzneimittelforschung; 2004; 54(3):187-91. PubMed ID: 15112866
[TBL] [Abstract][Full Text] [Related]
13. Laser-evoked potentials as a tool for assessing the efficacy of antinociceptive drugs.
Truini A; Panuccio G; Galeotti F; Maluccio MR; Sartucci F; Avoli M; Cruccu G
Eur J Pain; 2010 Feb; 14(2):222-5. PubMed ID: 19477145
[TBL] [Abstract][Full Text] [Related]
14. A data science approach to the selection of most informative readouts of the human intradermal capsaicin pain model to assess pregabalin effects.
Lötsch J; Walter C; Zunftmeister M; Zinn S; Wolters M; Ferreiros N; Rossmanith T; Oertel BG; Geisslinger G
Basic Clin Pharmacol Toxicol; 2020 Apr; 126(4):318-331. PubMed ID: 31608551
[TBL] [Abstract][Full Text] [Related]
15. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
Klein T; Magerl W; Hanschmann A; Althaus M; Treede RD
Eur J Pain; 2008 Jan; 12(1):17-29. PubMed ID: 17449306
[TBL] [Abstract][Full Text] [Related]
16. The Analgesic Effect of Oxytocin in Humans: A Double-Blind, Placebo-Controlled Cross-Over Study Using Laser-Evoked Potentials.
Paloyelis Y; Krahé C; Maltezos S; Williams SC; Howard MA; Fotopoulou A
J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26660859
[TBL] [Abstract][Full Text] [Related]
17. Analgesic potency of a new anticonvulsant drug versus acetylsalicylic acid via laser somatosensory evoked potentials. Randomized placebo-controlled double-blind (5-way) crossover study.
Schaffler K; Wauschkuhn CH; Gierend M
Arzneimittelforschung; 1991 Apr; 41(4):427-35. PubMed ID: 1859518
[TBL] [Abstract][Full Text] [Related]
18. Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain.
Andresen T; Staahl C; Oksche A; Mansikka H; Arendt-Nielsen L; Drewes AM
Br J Pharmacol; 2011 Oct; 164(3):934-45. PubMed ID: 21182491
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of capsaicin evoked trigeminal pain on warmth sensation and warmth evoked potentials.
Valeriani M; Tinazzi M; Le Pera D; Restuccia D; De Armas L; Maiese T; Tonali P; Arendt-Nielsen L
Exp Brain Res; 2005 Jan; 160(1):29-37. PubMed ID: 15316704
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, positive-controlled, 3-way cross-over human experimental pain study of a TRPV1 antagonist (V116517) in healthy volunteers and comparison with preclinical profile.
Arendt-Nielsen L; Harris S; Whiteside GT; Hummel M; Knappenberger T; O'Keefe S; Kapil R; Kyle D
Pain; 2016 Sep; 157(9):2057-2067. PubMed ID: 27168361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
